Wall Street MorningComparing OpGen (OPGN) and Editas Medicine (NASDAQ:EDIT)StockNewsTimesIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucle… Continue reading
STAT |
‘That’s $425000 right there’ — the anxious launch of a gene therapy with a record sticker price
STAT The treatment, developed after decades of research, is called Luxturna, and it is sometimes referred to as the first “true” gene therapy 6 to be approved by the Food and Drug Administration. Cancer treatments 7 such as Kymriah and Yescarta are also … |
Metro |
Blood cancer survivor, 56, meets the stem cell donor that saved his life
Metro A father of four who survived blood cancer has personally thanked the ‘genetic twin’ stem cell donor who saved his life. Peter Milburn’s health was rapidly failing before he was paired with ‘the only match in the world for me’, Aysha Lord, back in 2015 … Blood cancer survivor meets ‘genetic twin’ stem cell donorJersey Evening Post |
Medical Xpress |
Targeted immunotherapy treatment shows promise for treating advanced stage liver tumors
Medical Xpress Advanced stage liver tumors may be safely treated through image-guided injections of an immunotherapy approved for melanoma, according to a study presented today at the Society of Interventional Radiology’s Annual Scientific Meeting. Researchers found … |
|
Targeted immunotherapy treatment shows promise for treating advanced stage liver tumors
EurekAlert (press release) LOS ANGELES (March 21, 2018)–Advanced stage liver tumors may be safely treated through image-guided injections of an immunotherapy approved for melanoma, according to a study presented today at the Society of Interventional Radiology’s Annual … |
|
Targeted immunotherapy treatment shows promise for treating advanced stage liver tumors
EurekAlert (press release) LOS ANGELES (March 21, 2018)–Advanced stage liver tumors may be safely treated through image-guided injections of an immunotherapy approved for melanoma, according to a study presented today at the Society of Interventional Radiology’s Annual … |